http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678087-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ce072429e670635c822d1759f4661a1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0028
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61D7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0068
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61D7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-08
filingDate 2004-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea25b2dc32564ad15c776faf99129b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b98d47ca7f742958b8a529f801072a
publicationDate 2010-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7678087-B2
titleOfInvention Equine intranasal delivery system
abstract This invention relates to apparatus and methods of delivering various compositions including medicaments to a variety of targets. The invention includes a dose administrator ( 1 ) which may be used for intranasal delivery of compositions or medicaments, such as live virus vaccines, to both humans and animals. An axial collapse prevention element ( 2 ) to prevent excessive axial deflection of the dose administrator ( 1 ) or a dose-location coordinate indicator ( 3 ) to facilitate the delivery of a dose to the desired target location may be coupled to the dose administrator ( 1 ). An intranasal probe ( 4 ) having a force dissemination contact surface ( 7 ) may be responsive to a first end of the dose administrator ( 1 ). The dose may be delivered from a conformable dose sequestration element ( 10 ) through an aperture which penetrates the dose delivery aperture element ( 5 ) and the dose may be caused to stream by coupling a stream delivery element ( 6 ) to the dose delivery aperture element ( 5 ). The force application element ( 12 ) which acts upon the dose may be separated from the dose by a fluid dose propellent ( 13 ). While the invention may be used for numerous applications, it specifically addresses the difficulties of delivering cold-adapted live equine influenza viruses intranasally to equids.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8974771-B2
priorityDate 1999-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4962091-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4195076-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4029763-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3950512-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4554158-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4136168-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0444905-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5250298-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0444905-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4009258-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4800078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4132775-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5720762-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4693893-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3962422-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5158761-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4767416-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4613500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5843451-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3953592-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4110433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4554159-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5427782-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4110427-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3874083-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5484406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683137-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5215739-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3927208-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6716190-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4053583-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4512972-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136326756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127718929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129313279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821

Total number of triples: 63.